Company Premier Biomedical, Inc. Other OTC
Equities
BIEI
US74048K2033
Specialty Chemicals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gabe Vlad
DFI | Director of Finance/CFO | - | - |
William Tynan
AUD | Comptroller/Controller/Auditor | - | - |
General Counsel | - | - | |
Carl Eller
SAM | Sales & Marketing | - | 17-11-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 133,780 | 0 | 0 | 99.00 % |
Stock B | 1 | 1,098,879,075 | 1,087,891,076 ( 99.00 %) | 0 | |
Stock C | 0 | 2,000,000 | 0 | 0 |
Company contact information
Premier Biomedical, Inc.
2409 Sycamore Drive
37921, Knoxville
+724 633 7033
http://www.premierbiomedical.comSales per Business
1st Jan change | Capi. | |
---|---|---|
+17.80% | 66.73B | |
+2.92% | 49.79B | |
+19.98% | 42.5B | |
+20.88% | 26.45B | |
+12.04% | 19.66B | |
+1.27% | 17.18B | |
-22.98% | 15.82B | |
+2.77% | 15.56B | |
-9.25% | 15.41B |